Intec Pharma Reports Second Quarter 2019 Financial Results and Business Update – P&T Community

Related Articles:

• Intec Pharma Reports Second Quarter 2019 Financial Results and Business Update - BioSpace August 9, 2019 Intec Pharma Reports Second Quarter 2019 Financial Results and Business Update  BioSpacePublished: Aug 09, 2019. JERUSALEM, Aug. 9, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial ...
• Intec Pharma Reports First Quarter 2019 Financial Results and Corporate Update - P&T Community May 7, 2019 Intec Pharma Reports First Quarter 2019 Financial Results and Corporate Update  P&T CommunityJERUSALEM, May 7, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces financial results for the three ...
• Intec Pharma Reports Second Quarter 2019 Financial Results and Business Update - Yahoo Finance August 9, 2019 Intec Pharma Reports Second Quarter 2019 Financial Results and Business Update  Yahoo FinanceJERUSALEM, Aug. 9, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NTEC) ("Intec" or "the Company") today announces financial results for the three and six months ...
• Intec Pharma Reports First Quarter 2019 Financial Results and Corporate Update - Yahoo Finance May 7, 2019 Intec Pharma Reports First Quarter 2019 Financial Results and Corporate Update  Yahoo FinanceJERUSALEM, May 7, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NTEC) ("Intec" or "the Company") today announces financial results for the three months ended ...
• Intec Pharma Reports Third Quarter 2019 Financial Results and Provides Business Update - P&T Community November 12, 2019 Intec Pharma Reports Third Quarter 2019 Financial Results and Provides Business Update  P&T Community
• Intec Pharma Granted European Patent - P&T Community May 20, 2019 Intec Pharma Granted European Patent  P&T CommunityJERUSALEM, May 20, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the European Patent Office ...
• Intec Pharma to Participate at June Investment Conferences - P&T Community May 28, 2019 Intec Pharma to Participate at June Investment Conferences  P&T CommunityJERUSALEM, May 28, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that Company management will ...
• Intec Pharma Announces Results From Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Were Presented at the XXIV World Congress on Parkinson's Disease and Related Disorders June 19, 2019 JERUSALEM, June 19, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announced that results from a pharmacokinetics (PK) study of the Accordion Pill™-Carbidopa/Levodopa (AP-CD/LD) 50/500 mg dosed three times per day (TID) were highlighted yesterday in ...
• Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients - Yahoo Finance July 22, 2019 Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients  Yahoo FinanceConference Call to begin at 8:30 am ET. JERUSALEM, July 22, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NTEC) ("Intec" or "the Company") today announces ...
• Intec Pharma to Present Two Posters at International Congress of Parkinson's and Movement Disorder Society September 16, 2019 JERUSALEM, Sept. 16, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that two posters in support of the Company's Phase 3 clinical development program for the Accordion Pill™ Carbidopa/Levodopa (AP-CD/LD), will be presented at the upcoming...
• Intec Pharma to Participate in the HC Wainwright Global Life Sciences Conference - PRNewswire April 1, 2019 Intec Pharma to Participate in the HC Wainwright Global Life Sciences Conference  PRNewswireJERUSALEM, April 1, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that Company management will ...
• Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients July 22, 2019 JERUSALEM, July 22, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces top-line data from the Company's pivotal Phase 3 trial (the ACCORDANCE trial) evaluating the safety and efficacy of the Accordion Pill®-Carbidopa/Levodopa (AP-CD/LD)...
• Intec Pharma Announces Time Change for Presentation at Barclays Global Healthcare Conference - P&T Community March 13, 2019 Intec Pharma Announces Time Change for Presentation at Barclays Global Healthcare Conference  P&T CommunityJERUSALEM, March 13, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that the Company's ...
• Intec Pharma to Present Two Posters at International Congress of Parkinson's and Movement Disorder Society - P&T Community September 16, 2019 Intec Pharma to Present Two Posters at International Congress of Parkinson's and Movement Disorder Society  P&T CommunityJERUSALEM, Sept. 16, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that two posters in support of the ...
• Intec Pharma to Participate in the HC Wainwright Global Life Sciences Conference - BioSpace April 1, 2019 Intec Pharma to Participate in the HC Wainwright Global Life Sciences Conference  BioSpacePublished: Apr 01, 2019. JERUSALEM, April 1, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that ...
• Intec Pharma Granted European Patent - Yahoo Finance May 20, 2019 Intec Pharma Granted European Patent  Yahoo FinanceJERUSALEM, May 20, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NTEC) ("Intec" or "the Company") today announces that the European Patent Office has granted ...
• Intec Pharma Announces Results from Earlier Phase 2 Clinical Trial of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients Published in Parkinsonism and Related Disorders - P&T Community June 25, 2019 Intec Pharma Announces Results from Earlier Phase 2 Clinical Trial of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients Published in Parkinsonism and Related Disorders  P&T CommunityJERUSALEM, June 25, 2019 /PRNewswire/ --- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that results from an earlier ...
• Intec Pharma Highlights Potential of Accordion Pill® Oral Drug Delivery Platform in Two Posters at International Congress of Parkinson's and Movement Disorder Society September 25, 2019 JERUSALEM, Sept. 25, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that two posters highlighting data from the Company's Phase 3 clinical development program for the Accordion Pill® Carbidopa/Levodopa (AP-CD/LD), were presented yesterday...
• Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients - BioSpace July 22, 2019 Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients  BioSpacePublished: Jul 22, 2019. Conference Call to begin at 8:30 am ET. JERUSALEM, July 22, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or ...
• Intec Pharma to Present Two Posters at International Congress of Parkinson's and Movement Disorder Society - BioSpace September 16, 2019 Intec Pharma to Present Two Posters at International Congress of Parkinson's and Movement Disorder Society  BioSpacePublished: Sep 16, 2019. JERUSALEM, Sept. 16, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that ...